Trials / Completed
CompletedNCT03603132
A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics
Effects of Different Dosing and Feeding Intervals on the Pharmacokinetic Parameters of Herombopag Olamine Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study use a single-center, randomized, open, three-cycle, self-control trial design. It is planning to enroll 15 healthy adult male subjects. Fifteen subjects will randomize into 3 test groups which corresponding to 3 different dosing sequences. Subjects will be giving a single oral dose in per cycle, and there will have three types of breakfast administration after each treatment. Washing period is 10 days during the cycle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hetrombopag Olamine | 7.5mg in each cycle |
Timeline
- Start date
- 2018-07-14
- Primary completion
- 2018-08-17
- Completion
- 2018-08-17
- First posted
- 2018-07-27
- Last updated
- 2019-05-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03603132. Inclusion in this directory is not an endorsement.